Case study – AG1

Accelerating Evidence-Led Formulation with AI​

AG1, a leader in food supplements, wanted to formulate healthy products faster while maintaining high standards for safety and scientific rigor. By partnering with PIPA, the team used FIOS to accelerate innovation and support nutrition, bioactivity, safety, and regulatory targets through large-scale analysis of ingredient-condition relationships.

Approach

PIPA deployed the FIOS Develop engine to help AG1 identify evidence-grounded ingredient synergies and evaluate candidate formulations more efficiently. The platform surfaced ingredient synergies, assessed feasibility across regulatory, safety, sensory, and ingredient dimensions, and flagged formulation risks in minutes.

Impact
2 weeks to go from product concept to formulation.
40 candidate ingredient synergies in under 2 hours 
 
Evidence review timelines reduced from months to weeks.
<5 minutes to evaluate formulations against >200K products
 
A perspective the AG1 Team

“Nutrition science is complex, and translating discovery into products people can actually use has historically taken years. By investing in AI, we’re giving our scientific teams better tools to work faster and more rigorously. We can validate ideas sooner, make informed decisions earlier, and ultimately deliver higher-quality research-backed products to consumers.” Source: AG1

Kat Cole, CEO, AG1

Technologies
Develop

Let’s advance food innovation together

Unlock a faster path to food innovation by leveraging our AI platforms and tapping into the expertise of our top-class talent.

Stay informed with PIPA's latest updates and dive into the world of innovation.
Subscribe to our newsletter